000 01351 a2200385 4500
005 20250514064556.0
264 0 _c20040105
008 200401s 0 0 ger d
022 _a0028-2804
024 7 _a10.1007/s00115-003-1480-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDaffertshofer, M
245 0 0 _a[Heparin during acute ischemic stroke. Present data and clinical situation].
_h[electronic resource]
260 _bDer Nervenarzt
_cApr 2003
300 _a307-19 p.
_bdigital
500 _aPublication Type: Comparative Study; English Abstract; Journal Article; Review
650 0 4 _aAcute Disease
650 0 4 _aCerebral Infarction
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aCross-Cultural Comparison
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aGermany
650 0 4 _aHeparin
_xadverse effects
650 0 4 _aHeparin, Low-Molecular-Weight
_xadministration & dosage
650 0 4 _aHeparinoids
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aSurvival Rate
650 0 4 _aThrombolytic Therapy
650 0 4 _aTreatment Outcome
700 1 _aGrips, E
700 1 _aDempfle, C E
700 1 _aHennerici, M
773 0 _tDer Nervenarzt
_gvol. 74
_gno. 4
_gp. 307-19
856 4 0 _uhttps://doi.org/10.1007/s00115-003-1480-y
_zAvailable from publisher's website
999 _c12499057
_d12499057